These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19478447)

  • 1. Crystallization and preliminary X-ray studies of the N-domain of the Wilson disease associated protein.
    Liu L; O'Grady C; Dalrymple SA; Prasad L; Dmitriev OY; Delbaere LT
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jun; 65(Pt 6):621-4. PubMed ID: 19478447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
    Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
    Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
    Tsivkovskii R; Efremov RG; Lutsenko S
    J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of the nucleotide-binding domain of Wilson's disease protein: location of the ATP-binding site, domain dynamics and potential effects of the major disease mutations.
    Efremov RG; Kosinsky YA; Nolde DE; Tsivkovskii R; Arseniev AS; Lutsenko S
    Biochem J; 2004 Aug; 382(Pt 1):293-305. PubMed ID: 15147237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.
    Dmitriev O; Tsivkovskii R; Abildgaard F; Morgan CT; Markley JL; Lutsenko S
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5302-7. PubMed ID: 16567646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional insights of Wilson disease copper-transporting ATPase.
    Fatemi N; Sarkar B
    J Bioenerg Biomembr; 2002 Oct; 34(5):339-49. PubMed ID: 12539961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
    de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
    Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.
    Schushan M; Bhattacharjee A; Ben-Tal N; Lutsenko S
    Metallomics; 2012 Jul; 4(7):669-78. PubMed ID: 22692182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.
    Lutsenko S; Tsivkovskii R; Walker JM
    Ann N Y Acad Sci; 2003 Apr; 986():204-11. PubMed ID: 12763797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and functional reconstitution of the human Wilson copper ATPase, ATP7B.
    Portmann R; Solioz M
    FEBS Lett; 2005 Jul; 579(17):3589-95. PubMed ID: 15963506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.
    Morgan CT; Tsivkovskii R; Kosinsky YA; Efremov RG; Lutsenko S
    J Biol Chem; 2004 Aug; 279(35):36363-71. PubMed ID: 15205462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.
    Lutsenko S; Efremov RG; Tsivkovskii R; Walker JM
    J Bioenerg Biomembr; 2002 Oct; 34(5):351-62. PubMed ID: 12539962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.
    Dmitriev OY; Bhattacharjee A; Nokhrin S; Uhlemann EM; Lutsenko S
    J Biol Chem; 2011 May; 286(18):16355-62. PubMed ID: 21398519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structures of the actuator domain of ATP7A and ATP7B, the Menkes and Wilson disease proteins.
    Banci L; Bertini I; Cantini F; Migliardi M; Natile G; Nushi F; Rosato A
    Biochemistry; 2009 Aug; 48(33):7849-55. PubMed ID: 19645496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
    Cater MA; La Fontaine S; Mercer JF
    Biochem J; 2007 Jan; 401(1):143-53. PubMed ID: 16939419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding mode of ATP revealed by the solution structure of the N-domain of human ATP7A.
    Banci L; Bertini I; Cantini F; Inagaki S; Migliardi M; Rosato A
    J Biol Chem; 2010 Jan; 285(4):2537-44. PubMed ID: 19917612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.
    Dolgova NV; Olson D; Lutsenko S; Dmitriev OY
    Biochem J; 2009 Apr; 419(1):51-6, 3 p following 56. PubMed ID: 19173677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper transport and its defect in Wilson disease: characterization of the copper-binding domain of Wilson disease ATPase.
    Sarkar B
    J Inorg Biochem; 2000 Apr; 79(1-4):187-91. PubMed ID: 10830865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the ATP binding domain from the Archaeoglobus fulgidus Cu+-ATPase.
    Sazinsky MH; Mandal AK; Argüello JM; Rosenzweig AC
    J Biol Chem; 2006 Apr; 281(16):11161-6. PubMed ID: 16495228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction cycle of Thermotoga maritima copper ATPase and conformational characterization of catalytically deficient mutants.
    Hatori Y; Lewis D; Toyoshima C; Inesi G
    Biochemistry; 2009 Jun; 48(22):4871-80. PubMed ID: 19364131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.